Your browser doesn't support javascript.
loading
Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: Single center experience.
Zhang, Guo-Long; Keyal, Uma; Shi, Lei; Wang, Pei-Ru; Zhang, Ling-Lin; Bhatta, Anil Kumar; Wu, Yu-Hao; Fang, Shan; Wang, Xiu-Li.
Affiliation
  • Zhang GL; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Keyal U; Department of Dermatology, Nepal Mediciti Hospital, Kathmandu, Nepal.
  • Shi L; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang PR; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhang LL; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Bhatta AK; Department of Dermatology, Nepal Mediciti Hospital, Kathmandu, Nepal.
  • Wu YH; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Fang S; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang XL; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address: wangxiuli_1400023@tongji.edu.cn.
Photodiagnosis Photodyn Ther ; 32: 101980, 2020 Dec.
Article in En | MEDLINE | ID: mdl-32866632
The aim of this study was to demonstrate the efficacy of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) as an alternative treatment in cutaneous squamous cell carcinoma (cSCC) patients who are not fit for surgery. Thirty-three invasive cSCC patients who, for some reasons, cannot undergo surgery were enrolled in this study. All patients received plum blossom needle (PBN) pretreated ALA-PDT combined with topical application of 5% imiquimod cream. Two patients dropped the study because of severe pain and two patients discontinue treatment due to lack of response. Of 29 patients, who completed the treatment, 5 patients had complete response after 2-9 sessions of PDT and these patients had no recurrence till 18 months after treatment. Twenty-four patients achieved partial response and are satisfied with treatment outcome in terms of decreased symptoms and improved quality of life. PBN pretreated PDT in combination with topical imiquimod may be a viable treatment option for non resectable cSCC lesions.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Skin Neoplasms / Carcinoma, Squamous Cell Aspects: Patient_preference Limits: Humans Language: En Journal: Photodiagnosis Photodyn Ther Journal subject: DIAGNOSTICO POR IMAGEM / TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Photochemotherapy / Skin Neoplasms / Carcinoma, Squamous Cell Aspects: Patient_preference Limits: Humans Language: En Journal: Photodiagnosis Photodyn Ther Journal subject: DIAGNOSTICO POR IMAGEM / TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Country of publication: